Credit: Shutterstock photoSmall-cap stocks led Wall Street higher on Thursday, as U.S. markets experienced another riptide session of massive swings and overheated volume.
The Russell 2000 Index finished with a 5.4 percent gain, while the Standard & Poor's Small Cap 600 improved 5.3 percent.
Those performances were slightly better than those seen in the Dow Jones Industrial Average, which closed 4 percent higher; the Standard & Poor's 500, which rose 4.6 percent; and the Nasdaq Stock Market, which added 4.7 percent.
During Thursday's latest installment in the week of alternating massive rises and falls, small caps were led by technology and biopharmaceuticals.
Thursday's Top Performing Small Cap Stocks (Data provided by Google Finance)
A123 Systems (Nasdaq: AONE) : The developer and seller of advanced lithium-ion battery systems received a contract from GM for batteries to be used in future electric vehicles to be sold in various global markets.
Alliance HealthCare Services ( AIQ ) : Shares of the provider of outpatient diagnostic imaging and radiation oncology services bounced back from the previous day's nearly 56 percent sell-off.
K-V Pharmaceutical (NYSE: KV.A) : The specialty pharmaceutical maker, which focuses on women's health, held an investors conference on Thursday. This week, the company completed the sale of its Nesher generics subsidiary to Zydus.
Insmed (Nasdaq: INSM) : Shares of the biopharmaceutical, which focuses on inhaled treatments for lung diseases, have struggled since tanking Aug. 1 after the FDA halted phase III tests for its cystic fibrosis treatment Arikace over safety concerns.
Crimson Exploration (Nasdaq: CXPO) : The oil and gas explorer, with operations in South Texas and the Gulf Region, reported strong second-quarter results as it reversed a loss in the year-ago quarter, and issued optimistic third-quarter production guidance.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
